A MAJOR problem in the search for new antidepressant drugs is the lack of animal models which both resemble depressive illness and are selectively sensitive to clinically effective antidepressant treatments. We have been working on a new behavioural model in the rat which attempts to meet these two requirements. The method is based on the observation that a rat, when forced to swim in a situation from which there is no escape, will, after an initial period of vigorous activity, eventually cease to move altogether making only those movements necessary to keep its head above water. We think that this characteristic and readily identifiable behavioural immobility indicates a state of despair in which the rat has learned that escape is impossible and resigns itself to the experimental conditions. This hypothesis receives support from results presented below which indicate that immobility is reduced by different treatments known to be therapeutic in depression including three drugs, iprindole, mianserin and viloxazine which although clinically active1–3 show little or no ‘antidepressant’ activity in the usual animal tests4–6.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Ayd, F. J. Dis. Nerv. Syst. 30, 818–824 (1969).
Itil, T. M., Hsu, W. & Polvan, N. Curr. Ther. Res. clin. Exp. 14, 395–413 (1972).
Vivalan Symposium J. intern. Med. Res. 3, suppl. 3 (1975).
Gluckman, M. I. & Baum, T. Psychopharmacologia 15, 169–185 (1969).
Van Riezen, H., Behagel, I. R. H. & Chafik, M. Psychopharmac. Bull. 11, 10–15 (1975).
Greenwood, D. T. J. Intern. Med. Res. 3, suppl. 3, 18–30 (1975).
Jalfre, M. & Haefely, W. in 6-Hydroxydopamine and Catecholamine Neurons (eds Malmfors, T. & Thoenen, H.) 333–346 (North-Holland, Amsterdam, 1971).
Schildkraut, J. Am. J. Psychiat. 122, 509–522 (1965).
Helmchen, H. & Hippius, H. Nervenarzt 38, 455–458 (1967).
Prange, A. J. in The Nature and Treatment of Depression (eds Flach, F. F. & Draghi, S. C.) 255–270 (Wiley, New York, 1975).
Van Riezen, H. Arch. Intern. Pharmacodyn. 198, 256–269 (1972).
Kafoe, W. F. & Leonard, B. E. Arch. Intern. Pharmacodyn. 206, 389–391 (1973).
Jalfre, M., Ruch-Monachon, M. A. & Haefely, W. Adv. Biochem. Psychopharmac. 10, 121–134 (1974).
Fleischhauer, J., Al-Shaltchi, B. & Brândli, A. Arzneim. Forsch. 23, 1808–1813 (1973).
Dunnett, C. W. J. Am. Stat. Assoc. 50, 1096–1121 (1955).
About this article
Cite this article
PORSOLT, R., LE PICHON, M. & JALFRE, M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730–732 (1977). https://doi.org/10.1038/266730a0
Echinacoside exhibits antidepressant-like effects through AMPAR–Akt/ERK–mTOR pathway stimulation and BDNF expression in mice
Chinese Medicine (2022)
Alterations of monoamine neurotransmitters, HPA-axis hormones, and inflammation cytokines in reserpine-induced hyperalgesia and depression comorbidity rat model
BMC Psychiatry (2022)
Adult stress exposure blunts dopamine system hyperresponsivity in a neurodevelopmental rodent model of schizophrenia
Scientific Reports (2022)